The Safety and Efficacy Study of Vemurafenib (CT) Compared With Vemurafenib (Zelbolaf®) in Advanced Patients Harboring the V600 BRAF Mutation

Mise à jour : Il y a 4 ans
Référence :

Extrait


Critère d'inclusion

  • Advanced BRAF-mutant Cancers ,Advanced Cancers ,Colorectal Cancer ,Melanoma ,Recurrent/Refractory BRAFV600E-mutant Gliomas

Liens